The US House of Representatives, led by Republicans, has fulfilled its seven-year effort to undo the Affordable Care Act, commonly referred to as ‘Obamacare,’ voting to repeal and replace it by a narrow margin of 217-213 votes.
The revized bill, the original version of which six weeks ago failed to get congressional approval, next moves to the Senate, where Republican leaders must tread a fine line with only a two-vote margin, noted Reuters, pointing out that President Donald Trump’s victory could prove short-lived as the healthcare legislation heads into a likely tough battle in the Senate.
Despite holding the White House and controlling both houses of Congress, Republicans have found that overturning Obamacare is politically fraught, in part because of voter fears that many people will lose their health insurance as a result. Republicans have long criticized Obamacare as government overreach, said Paul Ryan (Republican, Wisconsin.), who has been working on the legislation since January but has failed to unite his ideologically divided caucus, commented The Washington Post.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze